+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Autoimmune Disease Diagnostic Market Size Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis

  • PDF Icon

    Report

  • 118 Pages
  • November 2021
  • Region: Global
  • Renub Research
  • ID: 5504332
Autoimmune diseases arise when the immune system fails to recognize the body's tissues and cells as self and alternatively mounts an immune response against the tissues, considering them foreign bodies. Depending on the type of illness a person has, autoimmune conditions can influence different body areas and upset the average growth and development of organs. According to American Autoimmune Related Diseases Association (AARDA), there are as many as 80 autoimmune disorders. Many of them have similar symptoms, and it is also possible to have more than one simultaneously. Autoimmune diseases ordinarily fluctuate intervening periods of remission (little or no symptoms) and flare-ups (worsening symptoms). According to the publisher, Global Autoimmune Diseases Diagnostic Market will be US$ 8.02 Billion by 2027.



Autoimmune Disease Diagnosis and Treatment Drives the Market


In autoimmune disease diagnostics, the autoantibody screening is acting as a medium to diagnose and monitor levels further to predict the progression of the disease. However, vague and slow to exhibit signs and symptoms present may mislead during analysis. Some of the more common symptoms of autoimmune disorders include fatigue, general feeling of being unwell (malaise), dizziness, joint pain, rash, and low-grade fever. Hence, laboratory tests are performed to diagnose autoimmune disorders depending on the particular condition the health practitioner suspects a person is suffering from. Besides, tests usually include blood tests for one or more auto antibodies. Tests for inflammation include such as C-reactive protein (CRP, the preferred test) and erythrocyte sedimentation rate (ESR).

Worldwide Autoimmune Diseases Diagnostics Industry will grow with a CAGR of 8.41% during 2021 to 2027


By Type, Systemic Autoimmune Diseases and Localized Autoimmune Disease Diagnostics are two significant types of Autoimmune Disease Diagnostic. Wherein, systemic autoimmune diseases are a broad range of related diseases characterized by dysregulation of the immune system, which activates immune cells to attack autoantigens and results in inappropriate inflammation and multi-tissue damages. Moreover, vital organs such as lung and kidney involvement in systemic autoimmune diseases are common and always presented in a progressive pattern with limited treatment strategy, making them be one of the most common causes of death in patients. These diseases are frequently conducted by clinical immunology/allergy specialists and rheumatologists.

Whilst localized (organ-specific) autoimmune diseases mainly affect a single organ or tissue. The effects frequently extend to other body systems and organs. Moreover, these diseases are often managed by organ-specific medical specialists, such as endocrinologists, gastroenterologists, neurologists or rheumatologists. As per our analysis, the market shares of Localized Autoimmune Disease Diagnostics are expected to be dominant throughout the forecast period.

Thyroiditis and Rheumatoid Arthritis top two amongst the most Common Autoimmune Diseases


By disease, the market is segmented into Systemic Lupus Erythematosus, Thyroiditis, Rheumatoid Arthritis, Sjögren's Syndrome and Scleroderma. As per our analysis, Thyroiditis and Rheumatoid Arthritis are the top two most common autoimmune diseases. Wherein thyroiditis have the highest market share as per our estimation which deals with the inflammation of the thyroid gland. Many etiologists of thyroiditis involve silent or subclinical thyroiditis, transient hyperthyroidism, acute and subacute infectious thyroiditis, and chronic autoimmune thyroiditis. Thyroid function examinations are used to strengthen thyroid disease, depending on results, and thyroid antibody tests may be considered to ensure an autoimmune cause of thyroiditis. Antithyroid antibody tests include tests for thyroid peroxidase (TPO) autoantibodies (TPOAb), thyroid-stimulating hormone (TSH) receptor autoantibodies (TRAb), and thyroglobulin (Tg) autoantibodies (TgAb).

Similarly, Rheumatoid arthritis standing second in the market share is a chronic joint disease that weakens the body's joints. It is also a systemic disease that potentially affects the body's internal organs and leads to disability. Rheumatoid arthritis is the most prevalent form of autoimmune, inflammatory arthritis in adults. It can also affect children. Therefore, the current approach is to treat rheumatoid arthritis aggressively with DMARDs (disease-modifying antirheumatic drugs) soon after diagnosis. Treating rheumatoid arthritis begins, within three to 12 months after indications begin, is the most excellent way to stop or slow the rise of the disease and bring about remission. Also, ongoing (long-term) treatment with combinations of medications may offer most people the best control and prognosis of rheumatoid arthritis.

Hospitals and Clinical Laboratories have well-established market share for Evaluating a Patient with a Suspected Autoimmune Disease


By End Users, the Autoimmune Disease Diagnostics Industry revolves around two main realms, namely Hospitals and Clinical Laboratories. Hospitals and Clinical Laboratories have well-established market share for evaluating a patient with suspected autoimmune disease. The results can strengthen a diagnosis, assess disease severity, aid in determining prognosis and are helpful to follow disease activity. Remarkably, the hospital and clinical laboratory examination components include complete blood count with differential, comprehensive metabolic panel, inflammatory markers, autoantibodies, and flow cytometry.

Regional Analysis: Global Autoimmune Disease Diagnostics Market Size was US$ 4.94 Billion in 2021


Based on Region, The Global Autoimmune Disease Diagnostics Market is classified into North America, Europe, Asia Pacific, Middle East & Africa and Latin America. As per our analysis, in Europe, the rising incidences of chronic diseases, the increasing geriatric population are the major factors spurring the autoimmune disease diagnosis industry growth, making it the most dominant in the market. Moreover, the Asia-Pacific is expected to show extensive market growth during the forecast period, owing to increasing disposable income and the growing patient pool in developing countries.

Cumulative Impact of COVID-19 on Autoimmune Disease:


Globally, the patients suffering from autoimmune disease feared the COVID-19 had severe adverse reactions or that the autoimmune condition may worsen amidst the pandemic. Consequently, these patients could be at a higher risk of severe COVID-19. Hence, the health providers working consistently for the patients promoted regular autoimmune disease diagnosis booming the industry growth.

Competitive Landscape booming the Global Autoimmune Disease Diagnostics Market:


Global Autoimmune Disease Diagnostics Market has the presence of many regional players who have many outlooks in emerging countries operating at regional or country-level with expertise and experience comprises the number of players functioning in the segment for years. Some of the significant players performing in the Autoimmune Disease Diagnostics Market are Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers and bioMerieux SA.

Further, these multi-national companies are developing products primarily for the autoimmune disease diagnosis segment to address the growing healthcare concerns regarding this disease. For instance, in March 2021, Roche launched Cobas pure integrated solutions analyzer to help simplify operations in small to medium-sized labs. Similarly, in May 2021, Siemens Healthineers also launched a new CT scanner for fast diagnosis and precise interventions in demanding clinical areas.

This report “Autoimmune Disease Diagnostic Market, Global Forecast By Type ( Systemic Autoimmune Disease Diagnostics and Localized Autoimmune Disease Diagnostics), Disease (Systemic Lupus Erythematosus, Thyroiditis, Rheumatoid Arthritis, Sjögren’s Syndrome, Scleroderma and Others), End Users (Hospitals, Clinical Laboratories and Others), Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America), Companies (Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers and bioMerieux SA)” provides a detailed analysis of Autoimmune Disease Diagnostic Industry.

Type – Autoimmune Disease Diagnostic Market have been covered from 2 viewpoints:


1. Systemic Autoimmune Disease Diagnostics
2. Localized Autoimmune Disease Diagnostics

Disease – Autoimmune Disease Diagnostic Market have been covered from 6 viewpoints:


1. Systemic Lupus Erythematosus
2. Thyroiditis
3. Rheumatoid Arthritis
4. Sjögren’s Syndrome
5. Scleroderma
6. Others

End Users – Autoimmune Disease Diagnostic Market have been covered from 3 viewpoints:


1. Hospitals
2. Clinical Laboratories
3. Others

Region – Autoimmune Disease Diagnostic Market have been covered from 5 viewpoints:


1. North America
2. Europe
3. Asia Pacific
4. Middle East & Africa
5. Latin America

Company Insights:

  • Overview
  • Recent Development & Strategies
  • Financial Insights

Company Covered:


1. Abbott Laboratories
2. Bio-Rad Laboratories
3. Roche Diagnostics
4. Siemens Healthineers
5. bioMerieux SA
1. General Mills Inc.
2. Nestle S.A.
3. Unilever
4. Baskin Robbins
5. Lotus Bakeries
Frequently Asked Questions about the Global Autoimmune Disease Diagnostic Market

What is the estimated value of the Global Autoimmune Disease Diagnostic Market?

The Global Autoimmune Disease Diagnostic Market was estimated to be valued at $4.94 Billion in 2021.

What is the growth rate of the Global Autoimmune Disease Diagnostic Market?

The growth rate of the Global Autoimmune Disease Diagnostic Market is 8.4%, with an estimated value of $8.02 Billion by 2027.

What is the forecasted size of the Global Autoimmune Disease Diagnostic Market?

The Global Autoimmune Disease Diagnostic Market is estimated to be worth $8.02 Billion by 2027.

Who are the key companies in the Global Autoimmune Disease Diagnostic Market?

Key companies in the Global Autoimmune Disease Diagnostic Market include Abbott Laboratories, Bio, Rad Laboratories, Roche Diagnostics and bioMerieux SA.

Table of Contents

1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Autoimmune Disease Diagnostics Market
6. Market Share – Autoimmune Disease Diagnostics Market
6.1 By Type
6.2 By Disease
6.3 By End Users
6.4 By Region
7. Type – Autoimmune Disease Diagnostics Market
7.1 Systemic Autoimmune Disease Diagnostics
7.2 Localized Autoimmune Disease Diagnostics
8. Disease – Autoimmune Disease Diagnostics Market
8.1 Systemic Lupus Erythematosus
8.2 Thyroiditis
8.3 Rheumatoid Arthritis
8.4 Sjögren’s Syndrome
8.5 Scleroderma
8.6 Others
9. End Users – Autoimmune Disease Diagnostics Market
9.1 Hospitals
9.2 Clinical Laboratories
9.3 Others
10. Region – Autoimmune Disease Diagnostics Market
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 Middle East & Africa
10.5 Latin America
11. Porters Five Forces
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12. Company Analysis
12.1 Abbott Laboratories
12.1.1 Overview
12.1.2 Recent Development
12.1.3 Financial Insights
12.2 Bio-Rad Laboratories
12.2.1 Overview
12.2.2 Recent Development
12.2.3 Financial Insights
12.3 Roche Diagnostics
12.3.1 Overview
12.3.2 Recent Development
12.3.3 Financial Insights
12.4 Siemens Healthineers
12.4.1 Overview
12.4.2 Recent Development
12.4.3 Financial Insights
12.5 bioMerieux SA
12.5.1 Overview
12.5.2 Recent Development
12.5.3 Financial Insights
List Of Figures:
Figure-01: Global Autoimmune Disease Diagnostics Market (Billion US$), 2016 – 2021
Figure-02: Forecast for – Global Autoimmune Disease Diagnostics Market (Billion US$), 2022 – 2027
Figure-03: Type – Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2016 – 2021
Figure-04: Type – Forecast for Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2022 – 2027
Figure-05: Type – Localized Autoimmune Disease Diagnostics Market (Billion US$), 2016 – 2021
Figure-06: Type – Forecast for Localized Autoimmune Disease Diagnostics Market (Billion US$), 2022 – 2027
Figure-07: Disease – Systemic Lupus Erythematosus Market (Million US$), 2016 – 2021
Figure-08: Disease – Forecast for Systemic Lupus Erythematosus Market (Million US$), 2022 – 2027
Figure-09: Disease – Thyroiditis Market (Million US$), 2016 – 2021
Figure-10: Disease – Forecast for Thyroiditis Market (Million US$), 2022 – 2027
Figure-11: Disease – Rheumatoid Arthritis Market (Million US$), 2016 – 2021
Figure-12: Disease – Forecast for Rheumatoid Arthritis Market (Million US$), 2022 – 2027
Figure-13: Disease – Sjögren’s Syndrome Market (Million US$), 2016 – 2021
Figure-14: Disease – Forecast for Sjögren’s Syndrome Market (Million US$), 2022 – 2027
Figure-15: Disease – Scleroderma Market (Million US$), 2016 – 2021
Figure-16: Disease – Forecast for Scleroderma Market (Million US$), 2022 – 2027
Figure-17: Disease – Others Market (Million US$), 2016 – 2021
Figure-18: Disease – Forecast for Others Market (Million US$), 2022 – 2027
Figure-19: End Users – Hospitals Market (Billion US$), 2016 – 2021
Figure-20: End Users – Forecast for Hospitals Market (Billion US$), 2022 – 2027
Figure-21: End Users – Clinical Laboratories Market (Billion US$), 2016 – 2021
Figure-22: End Users – Forecast for Clinical Laboratories Market (Billion US$), 2022 – 2027
Figure-23: End Users – Others Market (Million US$), 2016 – 2021
Figure-24: End Users – Forecast for Others Market (Million US$), 2022 – 2027
Figure-25: North America – Autoimmune Disease Diagnostic Market (Million US$), 2016 – 2021
Figure-26: North America – Forecast for Autoimmune Disease Diagnostic Market (Million US$), 2022 – 2027
Figure-27: Europe – Autoimmune Disease Diagnostic Market (Billion US$), 2016 – 2021
Figure-28: Europe – Forecast for Autoimmune Disease Diagnostic Market (Billion US$), 2022 – 2027
Figure-29: Asia Pacific – Autoimmune Disease Diagnostic Market (Million US$), 2016 – 2021
Figure-30: Asia Pacific – Forecast for Autoimmune Disease Diagnostic Market (Million US$), 2022 – 2027
Figure-31: Middle East & Africa – Autoimmune Disease Diagnostic Market (Million US$), 2016 – 2021
Figure-32: Middle East & Africa – Forecast for Autoimmune Disease Diagnostic Market (Million US$), 2022 – 2027
Figure-33: Latin America – Autoimmune Disease Diagnostic Market (Million US$), 2016 – 2021
Figure-34: Latin America – Forecast for Autoimmune Disease Diagnostic Market (Million US$), 2022 – 2027
Figure-35: Abbott Laboratories – Global Revenue (Billion US$), 2016 – 2021
Figure-36: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-37: Bio-Rad Laboratories – Global Revenue (Billion US$), 2016 – 2021
Figure-38: Bio-Rad Laboratories – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-39: Roche Diagnostics – Global Revenue (Billion US$), 2016 – 2021
Figure-40: Roche Diagnostics – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-41: Siemens Healthineers – Global Revenue (Billion US$), 2016 – 2021
Figure-42: Siemens Healthineers – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-43: bioMerieux SA – Global Revenue (Billion US$), 2016 – 2021
Figure-44: bioMerieux SA – Forecast for Global Revenue (Billion US$), 2022 – 2027
List Of Figures:
Table-01: Global – Autoimmune Disease Diagnostic Market Share by Type (Percent), 2016 – 2021
Table-02: Global – Forecast for Autoimmune Disease Diagnostic Market Share by Type (Percent), 2022 – 2027
Table-03: Global – Autoimmune Disease Diagnostic Market Share by Disease (Percent), 2016 – 2021
Table-04: Global – Forecast for Autoimmune Disease Diagnostic Market Share by Disease (Percent), 2022 – 2027
Table-05: Global – Autoimmune Disease Diagnostic Market Share by End User (Percent), 2016 – 2021
Table-06: Global – Forecast for Autoimmune Disease Diagnostic Market Share by End User (Percent), 2022 – 2027
Table-07: Global – Autoimmune Disease Diagnostic Market Share by Region (Percent), 2016 – 2021
Table-08: Global – Forecast for Autoimmune Disease Diagnostic Market Share by Region (Percent), 2022 – 2027

Companies Mentioned

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • bioMerieux SA

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...